Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Surveillance and management of urologic complications after spinal cord injury.

Kreydin E, Welk B, Chung D, Clemens Q, Yang C, Danforth T, Gousse A, Kielb S, Kraus S, Mangera A, Reid S, Szell N, Cruz F, Chartier-Kastler E, Ginsberg DA.

World J Urol. 2018 May 29. doi: 10.1007/s00345-018-2345-0. [Epub ahead of print]

PMID:
29845320
2.

Impact of night shifts on emergency medicine resident resuscitation performance.

Edgerley S, McKaigney C, Boyne D, Ginsberg D, Dagnone JD, Hall AK.

Resuscitation. 2018 Jun;127:26-30. doi: 10.1016/j.resuscitation.2018.03.019. Epub 2018 Mar 12.

PMID:
29545141
3.

New insights on the regulation of INK4/ARF locus expression.

Gamell C, Ginsberg D, Haupt S, Haupt Y.

Oncotarget. 2017 Nov 1;8(63):106147-106148. doi: 10.18632/oncotarget.22258. eCollection 2017 Dec 5. No abstract available.

4.

Surviving Fournier's gangrene: Multivariable analysis and a novel scoring system to predict length of stay.

Ghodoussipour SB, Gould D, Lifton J, Badash I, Krug A, Miranda G, Loh-Doyle J, Carey J, Djaladat H, Doumanian L, Ginsberg D.

J Plast Reconstr Aesthet Surg. 2018 May;71(5):712-718. doi: 10.1016/j.bjps.2017.12.005. Epub 2017 Dec 14.

PMID:
29284566
5.

Neobladder-Vaginal fistula: The University of Southern California experience.

Rosenberg S, Miranda G, Ginsberg DA.

Neurourol Urodyn. 2018 Apr;37(4):1380-1385. doi: 10.1002/nau.23454. Epub 2017 Nov 15.

PMID:
29140545
6.

Laser-Induced Neocollagenesis in Focal Dermal Hypoplasia Associated With Goltz Syndrome in a Girl.

Krakowski AC, Ozog DM, Ginsberg D, Cheng C, Chaffins ML.

JAMA Dermatol. 2017 Dec 1;153(12):1292-1297. doi: 10.1001/jamadermatol.2017.3669.

PMID:
28975212
7.

Firm Erythematous Nodules in a Hospitalized Infant.

Ginsberg DN, Cheng CE, Barrio VR.

Pediatr Dermatol. 2017 Sep;34(5):614-616. doi: 10.1111/pde.13245. No abstract available.

PMID:
28884920
8.

ASK1 (MAP3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity, molecularly defining a human dys-metabolic obese phenotype.

Haim Y, Blüher M, Konrad D, Goldstein N, Klöting N, Harman-Boehm I, Kirshtein B, Ginsberg D, Tarnovscki T, Gepner Y, Shai I, Rudich A.

Mol Metab. 2017 May 6;6(7):725-736. doi: 10.1016/j.molmet.2017.05.003. eCollection 2017 Jul.

9.

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis.

Drake MJ, Nitti VW, Ginsberg DA, Brucker BM, Hepp Z, McCool R, Glanville JM, Fleetwood K, James D, Chapple CR.

BJU Int. 2017 Nov;120(5):611-622. doi: 10.1111/bju.13945. Epub 2017 Aug 2. Review.

PMID:
28670786
10.

Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline.

Kobashi KC, Albo ME, Dmochowski RR, Ginsberg DA, Goldman HB, Gomelsky A, Kraus SR, Sandhu JS, Shepler T, Treadwell JR, Vasavada S, Lemack GE.

J Urol. 2017 Oct;198(4):875-883. doi: 10.1016/j.juro.2017.06.061. Epub 2017 Jun 15.

PMID:
28625508
11.

Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder.

Ginsberg DA, Drake MJ, Kaufmann A, Radomski S, Gousse AE, Chermansky CJ, Magyar A, Nicandro JP, Nitti VW; 191622-096 Investigators.

J Urol. 2017 Oct;198(4):897-904. doi: 10.1016/j.juro.2017.05.068. Epub 2017 May 20.

PMID:
28536084
12.

The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells.

Brodie S, Lee HK, Jiang W, Cazacu S, Xiang C, Poisson LM, Datta I, Kalkanis S, Ginsberg D, Brodie C.

Oncotarget. 2017 May 9;8(19):31785-31801. doi: 10.18632/oncotarget.15991.

13.

A novel lncRNA, GASL1, inhibits cell proliferation and restricts E2F1 activity.

Gasri-Plotnitsky L, Ovadia A, Shamalov K, Nizri-Megnaji T, Meir S, Zurer I, Cohen CJ, Ginsberg D.

Oncotarget. 2017 Apr 4;8(14):23775-23786. doi: 10.18632/oncotarget.15864.

14.

Editorial Comment.

Ginsberg DA.

J Urol. 2017 Jul;198(1):210. doi: 10.1016/j.juro.2017.01.113. Epub 2017 Apr 7. No abstract available.

PMID:
28396059
15.

Urologic Management and Complications in Spinal Cord Injury Patients: A 40- to 50-year Follow-up Study.

Gao Y, Danforth T, Ginsberg DA.

Urology. 2017 Jun;104:52-58. doi: 10.1016/j.urology.2017.03.006. Epub 2017 Mar 16.

PMID:
28322903
16.

Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.

Gamell C, Gulati T, Levav-Cohen Y, Young RJ, Do H, Pilling P, Takano E, Watkins N, Fox SB, Russell P, Ginsberg D, Monahan BJ, Wright G, Dobrovic A, Haupt S, Solomon B, Haupt Y.

Sci Signal. 2017 Jan 10;10(461). pii: eaaf8223. doi: 10.1126/scisignal.aaf8223.

PMID:
28074012
17.

OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder: Pro.

Ginsberg DA.

J Urol. 2017 Jan;197(1):11-13. doi: 10.1016/j.juro.2016.10.033. Epub 2016 Oct 11. No abstract available.

PMID:
27742453
18.

Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications.

Rac G, Younger A, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, MacLachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner ES.

Neurourol Urodyn. 2017 Apr;36(4):1155-1160. doi: 10.1002/nau.23080. Epub 2016 Jul 26.

PMID:
27460448
19.

Debates in allergy medicine: Specific immunotherapy in children with atopic dermatitis, the "con" view.

Ginsberg DN, Eichenfield LF.

World Allergy Organ J. 2016 Apr 18;9:16. doi: 10.1186/s40413-016-0107-2. eCollection 2016.

20.

Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study.

Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, De Ridder D, Jenkins B, Magyar A, Chapple C; 191622-096 Investigators.

J Urol. 2016 Sep;196(3):791-800. doi: 10.1016/j.juro.2016.03.146. Epub 2016 Mar 30.

PMID:
27038769
21.

Outcomes of Autologous Fascia Pubovaginal Sling for Patients with Transvaginal Mesh Related Complications Requiring Mesh Removal.

McCoy O, Vaughan T, Nickles SW, Ashley M, MacLachlan LS, Ginsberg D, Rovner E.

J Urol. 2016 Aug;196(2):484-9. doi: 10.1016/j.juro.2016.02.2976. Epub 2016 Mar 17.

PMID:
26997314
22.

Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison.

Freemantle N, Ginsberg DA, McCool R, Fleetwood K, Arber M, Khalaf K, Loveman C, Ni Q, Glanville J.

BMJ Open. 2016 Feb 23;6(2):e009122. doi: 10.1136/bmjopen-2015-009122.

23.

Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications.

Younger A, Rac G, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, Maclachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner E.

Urology. 2016 May;91:46-51. doi: 10.1016/j.urology.2015.12.057. Epub 2016 Feb 1.

PMID:
26845051
24.

LncRNA Khps1 Regulates Expression of the Proto-oncogene SPHK1 via Triplex-Mediated Changes in Chromatin Structure.

Postepska-Igielska A, Giwojna A, Gasri-Plotnitsky L, Schmitt N, Dold A, Ginsberg D, Grummt I.

Mol Cell. 2015 Nov 19;60(4):626-36. doi: 10.1016/j.molcel.2015.10.001.

25.

Elevated autophagy gene expression in adipose tissue of obese humans: A potential non-cell-cycle-dependent function of E2F1.

Haim Y, Blüher M, Slutsky N, Goldstein N, Klöting N, Harman-Boehm I, Kirshtein B, Ginsberg D, Gericke M, Guiu Jurado E, Kovsan J, Tarnovscki T, Kachko L, Bashan N, Gepner Y, Shai I, Rudich A.

Autophagy. 2015 Nov 2;11(11):2074-2088.

26.

A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel.

Bida O, Gidoni M, Ideses D, Efroni S, Ginsberg D.

Oncotarget. 2015 Sep 29;6(29):27880-90. doi: 10.18632/oncotarget.4944.

27.

Improving Outcomes in Patients With Refractory Idiopathic and Neurogenic Detrusor Overactivity: Management Strategies.

Ginsberg DA, Schneider LK, Watanabe TK.

Arch Phys Med Rehabil. 2015 Sep;96(9 Suppl):S341-57.e1. doi: 10.1016/j.apmr.2015.05.016.

PMID:
26318392
28.

TODRA, a lncRNA at the RAD51 Locus, Is Oppositely Regulated to RAD51, and Enhances RAD51-Dependent DSB (Double Strand Break) Repair.

Gazy I, Zeevi DA, Renbaum P, Zeligson S, Eini L, Bashari D, Smith Y, Lahad A, Goldberg M, Ginsberg D, Levy-Lahad E.

PLoS One. 2015 Jul 31;10(7):e0134120. doi: 10.1371/journal.pone.0134120. eCollection 2015.

29.

Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life.

Satkunasivam R, Santomauro M, Chopra S, Plotner E, Cai J, Miranda G, Salibian S, Aron M, Ginsberg D, Daneshmand S, Desai M, Gill IS.

Eur Urol. 2016 Feb;69(2):247-53. doi: 10.1016/j.eururo.2015.06.041. Epub 2015 Jul 9.

PMID:
26164417
30.

Outcomes of Male Sling Mesh Kit Placement in Patients with Neuropathic Stress Urinary Incontinence: A Single Institution Experience.

Vainrib M, Reyblat P, Ginsberg D.

Urol Int. 2015;95(4):406-10. doi: 10.1159/000381880. Epub 2015 May 6.

PMID:
25969383
31.

Editorial comment.

Ginsberg DA.

J Urol. 2015 Jun;193(6):2094; discussion 2094. doi: 10.1016/j.juro.2015.01.118. Epub 2015 Mar 20. No abstract available.

PMID:
25797541
32.

Pseudocarcinomatous hyperplasia mimicking squamous cell carcinoma in a case of CD56-positive cytotoxic T-cell lymphoma.

Ginsberg D, Hill H, Wilson B, Plaza JA, Schieke SM.

J Cutan Pathol. 2015 Mar;42(3):194-8. doi: 10.1111/cup.12421. Epub 2014 Dec 8.

PMID:
25370871
33.

Neurogenic bladder: from diagnosis to management.

Goldmark E, Niver B, Ginsberg DA.

Curr Urol Rep. 2014 Oct;15(10):448. doi: 10.1007/s11934-014-0448-8. Review.

PMID:
25118855
34.

Long-term efficacy of repeat incisions of bladder neck/external sphincter in patients with spinal cord injury.

Vainrib M, Reyblat P, Ginsberg DA.

Urology. 2014 Oct;84(4):940-5. doi: 10.1016/j.urology.2014.06.009. Epub 2014 Aug 5.

PMID:
25102789
35.

Robotic sacrocolpopexy.

Danforth TL, Aron M, Ginsberg DA.

Indian J Urol. 2014 Jul;30(3):318-25. doi: 10.4103/0970-1591.128502.

36.

Neurogenic lower urinary tract dysfunction: how, when, and with which patients do we use urodynamics?

Danforth TL, Ginsberg DA.

Urol Clin North Am. 2014 Aug;41(3):445-52, ix. doi: 10.1016/j.ucl.2014.04.003. Epub 2014 May 22. Review.

PMID:
25063601
37.

Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.

Tang DH, Colayco DC, Khalaf KM, Piercy J, Patel V, Globe D, Ginsberg D.

BJU Int. 2014 Mar;113(3):484-91. doi: 10.1111/bju.12505.

38.

Optimizing therapy and management of neurogenic bladder.

Ginsberg D.

Am J Manag Care. 2013;19(10 Suppl):s197-204.

39.

The epidemiology and pathophysiology of neurogenic bladder.

Ginsberg D.

Am J Manag Care. 2013;19(10 Suppl):s191-6.

40.

The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage.

Feldstein O, Nizri T, Doniger T, Jacob J, Rechavi G, Ginsberg D.

Mol Cancer. 2013 Oct 29;12(1):131. doi: 10.1186/1476-4598-12-131.

41.

OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology.

Ginsberg D, Cruz F, Herschorn S, Gousse A, Keppenne V, Aliotta P, Sievert KD, Brin MF, Jenkins B, Thompson C, Lam W, Heesakkers J, Haag-Molkenteller C.

Adv Ther. 2013 Sep;30(9):819-33. doi: 10.1007/s12325-013-0054-z. Epub 2013 Sep 27. Erratum in: Adv Ther. 2014 Feb;31(2):242.

42.

Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.

Ginsberg D, Schneider T, Kelleher C, Van Kerrebroeck P, Swift S, Creanga D, Martire DL.

BJU Int. 2013 Aug;112(3):373-85. doi: 10.1111/bju.12174.

43.

Potential risk factors and outcomes of artificial urinary sphincter placement after radical cystectomy and orthotopic neobladder urinary diversion.

Vainrib M, Simma-Chiang V, Boyd SD, Ginsberg DA.

Neurourol Urodyn. 2013 Sep;32(7):1010-3. doi: 10.1002/nau.22345. Epub 2013 Apr 17.

PMID:
23595916
44.

Supine and upright urodynamic evaluation of incontinent ileovesicostomy in wheelchair-bound adults with neurogenic bladder.

Vainrib M, Reyblat P, Kong WG, Ginsberg DA.

Spinal Cord. 2013 Aug;51(8):634-6. doi: 10.1038/sc.2013.26. Epub 2013 Apr 16.

PMID:
23588571
45.

A prop to explain LDL particles.

Ginsberg DC.

J Clin Lipidol. 2013 Jan-Feb;7(1):88-9. doi: 10.1016/j.jacl.2012.02.009. Epub 2012 Feb 20. No abstract available.

PMID:
23351587
46.

Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty.

Vainrib M, Reyblat P, Ginsberg DA.

Neurourol Urodyn. 2013 Mar;32(3):250-3. doi: 10.1002/nau.22304. Epub 2012 Sep 10.

PMID:
22965686
47.
48.

RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.

Feldstein O, Ben-Hamo R, Bashari D, Efroni S, Ginsberg D.

Mol Cancer Res. 2012 Sep;10(9):1169-77. Epub 2012 Jul 13.

49.

Editorial comment.

Ginsberg DA.

Urology. 2012 Aug;80(2):464-5. doi: 10.1016/j.urology.2012.03.040. Epub 2012 Jun 15. No abstract available.

PMID:
22704176
50.

Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.

Ginsberg D, Gousse A, Keppenne V, Sievert KD, Thompson C, Lam W, Brin MF, Jenkins B, Haag-Molkenteller C.

J Urol. 2012 Jun;187(6):2131-9. doi: 10.1016/j.juro.2012.01.125. Epub 2012 Apr 12.

PMID:
22503020

Supplemental Content

Loading ...
Support Center